Johnson & Johnson Amends CVRx Stake, Signals Ownership Change
Ticker: CVRX · Form: SC 13G/A · Filed: Feb 2, 2024 · CIK: 1235912
| Field | Detail |
|---|---|
| Company | Cvrx, Inc. (CVRX) |
| Form Type | SC 13G/A |
| Filed Date | Feb 2, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | mixed |
Complexity: simple
Sentiment: mixed
Topics: institutional-ownership, amendment, portfolio-change
TL;DR
**J&J just updated its CVRx stake, likely reducing its position.**
AI Summary
Johnson & Johnson (J&J) filed an amended Schedule 13G/A on February 2, 2024, indicating a change in their beneficial ownership of CVRx, Inc. (CVRX) common stock as of December 31, 2023. This filing, an Amendment No. 1, updates their previous disclosure, signaling that J&J no longer holds a reportable stake above the 5% threshold, or has changed the nature of their beneficial ownership. This matters to investors because it suggests J&J, a major healthcare player, has reduced or divested its significant passive investment in CVRX, which could be interpreted as a loss of confidence or a strategic portfolio adjustment.
Why It Matters
This filing indicates Johnson & Johnson has altered its significant passive investment in CVRx, potentially signaling a shift in their strategic interest or a portfolio rebalancing. Investors should note this as a major institutional investor has changed its position.
Risk Assessment
Risk Level: medium — The change in a major institutional investor's position, like Johnson & Johnson's, can introduce uncertainty and potentially impact investor sentiment for CVRx, Inc.
Analyst Insight
An investor should investigate the reasons behind Johnson & Johnson's change in ownership and monitor CVRx, Inc.'s stock performance and future institutional ownership filings for further insights.
Key Numbers
- 126638105 — CUSIP Number (identifies CVRx, Inc. Common Stock)
- 0000904454-24-000094 — Accession Number (unique identifier for this specific SEC filing)
- 20240202 — Filing Date (the date this SC 13G/A was filed with the SEC)
Key Players & Entities
- Johnson & Johnson (company) — the reporting person filing the SC 13G/A
- CVRx, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- $0.01 (dollar_amount) — par value per share of CVRx Common Stock
Forward-Looking Statements
- Johnson & Johnson has likely reduced its beneficial ownership in CVRx, Inc. below the 5% threshold. (Johnson & Johnson) — high confidence, target: N/A
- The change in Johnson & Johnson's stake could lead to increased volatility in CVRx, Inc.'s stock price in the short term. (CVRx, Inc.) — medium confidence, target: Q1 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, specifically an Amendment No. 1, filed pursuant to Rule 13d-1(d) of the Securities Exchange Act of 1934.
Who is the reporting person in this filing?
The reporting person is Johnson & Johnson, with a Central Index Key (CIK) of 0000200406.
What is the subject company whose securities are being reported?
The subject company is CVRx, Inc., with a Central Index Key (CIK) of 0001235912.
What is the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' is December 31, 2023.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock, par value $0.01 per share, of CVRx, Inc. is 126638105.
Filing Stats: 840 words · 3 min read · ~3 pages · Grade level 8 · Accepted 2024-02-02 16:52:17
Key Financial Figures
- $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti
Filing Documents
- s13ga_123123-cvrx.htm (SC 13G/A) — 35KB
- 0000904454-24-000094.txt ( ) — 37KB
(c). Citizenship
Item 2(c). Citizenship J&J: New Jersey JJDC: Delaware
Ownership
Item 4. Ownership (a) through (c): The information requested in these paragraphs is incorporated by reference to the cover pages to this Amendment No. 1 to Schedule 13G. CUSIP No. 126638105 Page 5 SIGNATURE After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: February 2, 2024 JOHNSON & JOHNSON By: /s/ Marc Larkins Name: Marc Larkins Title: Secretary JOHNSON & JOHNSON INNOVATION-JJDC, INC. By: /s/ Jill McManus Name: Jill McManus Title: Assistant Treasurer